Interactive demonstration · synthetic data

Specialist clinic letter.

A cardiology outpatient letter with a clear dose instruction, a test request, conditional advice and a discharge back to the practice.

Each scenario has its own address, and the address keeps your place, so you can share it or come back to it. Reset at any time.

Take the 90-second tourA scripted walkthrough of the clinic-letter scenario, from receipt to evidence. Pause, step or skip at any point; synthetic data throughout.
Synthetic

Illustrative product demonstration using synthetic clinical information. It does not establish the clinical accuracy, safety or readiness of the product. Nothing is saved to any clinical record, and nothing you do here is sent anywhere.

ReedleySynthetic
Funmilayo ADEYEMI synthetic patient64 y · DOB 3 Jun 1962 · NHS 999 000 0069 · Synthetic Practice
Identity matchedClassified Outpatient clinic letter · Cardiology

Step 1 of 3 Open an item to see the passage it came from, then accept, edit or reject it. 0 of 4 decided.

Source document

Numbers mark the passages each item cites.
Northfield General Hospital (fictional)Cardiology outpatientsOutpatient clinic letterClinic 30 Sep 2026 · Typed 2 Oct 2026 · Received 4 Oct 2026 08:31Patient: Funmilayo ADEYEMI · DOB 3 Jun 1962 · NHS 999 000 0069

Diagnosis

Essential hypertension. Ambulatory blood pressure average 152/91 mmHg.

Clinical summary

Mrs Adeyemi attended for review of her blood pressure. Home readings remain above target despite ramipril 5 mg and amlodipine 10 mg. She reports some ankle swelling in the evenings. An echocardiogram today was normal.

Plan

I would be grateful if you could increase ramipril to 10 mg once daily1 and recheck renal function in 1–2 weeks25.

Consider stopping amlodipine if ankle swelling persists.3

Follow-up

I have not arranged further cardiology follow-up and have discharged her back to your care. Please review her blood pressure in 4–6 weeks.4

Synthetic document created for demonstration. Not a real patient.

Proposed work 5

Each item shows the findings and the exact passages it comes from. Open one to decide on it.

  1. Item 1 of 5: Medication changeReview the ramipril dose change requested by cardiologyAction needed

    From the document

    • Dose instructionRecord differs

      Increase ramipril to 10 mg once daily

      Record Record shows ramipril 5 mg once daily.

      Why Reedley says this Dose and frequency are stated explicitly as a request to the practice.

    Proposed work

    The letter asks for 10 mg once daily; the record shows 5 mg.

    Owner
    Clinical pharmacist
    Due
    Within 2 working days
    Who decides
    Prescriber decision required

    Verified when: Active medication and latest issue show ramipril 10 mg once daily. Source: Clinical record, by design; simulated here.

    Limit It does not show that the patient has collected or is taking the medicine (issued is not taken).

    Reedley does not change doses. A prescriber decides and acts in the clinical system.

    Reedley proposes; a named person decides. Nothing happens until you do.

  2. Item 2 of 5: InvestigationRenal function 1–2 weeks after any dose changeAfter dose change

    From the document

    Proposed work

    Requested in the plan alongside the dose change.

    Owner
    Admin team
    Due
    1–2 weeks after the dose change
    Who decides
    Administrative
    After
    Item 1: Review the ramipril dose change requested by cardiology

    Verified when: A U&E result for this patient received 1–2 weeks after the dose change. A booking alone is not enough. Source: Pathology, by design; simulated here.

    Limit A received result is not a reviewed result. The clinician review is its own item, and this item is designed to close only after that review is recorded (the development build closes it on receipt).

    Reedley does not book tests. The practice books through its own system.

    Reedley proposes; a named person decides. Nothing happens until you do.

  3. Item 3 of 5: Clinician decisionClinician decision on the conditional amlodipine adviceRouted to GP · Identified

    From the document

    • Conditional adviceReview required

      “Consider stopping amlodipine if ankle swelling persists”

      Reedley cannot tell whether a change was intended. A clinician should decide.

      Record Record shows amlodipine 10 mg once daily.

      Why Reedley says this Conditional wording (“consider”, “if”) is never treated as an instruction.

    Routed to a clinician · no task proposed

    Conditional wording (“consider”, “if”) is never turned into a medication task. It goes to a clinician to decide; it rests at identified, awaiting the GP, until a named person decides.

    Clinician
    GP
    Due
    Within 7 days (draft routing rule)
    Who decides
    Clinician decision required

    Verified when: A decision recorded by a named clinician, with the date. Source: Clinical record, by design; simulated here.

    Limit It shows that a decision was recorded, not what it should be.

    No medication task is created. Reedley does not decide whether to stop a medicine.

    Already in the work queue for a clinician’s decision
  4. Item 4 of 5: Timed reviewBlood pressure review in 4–6 weeksTimed review

    From the document

    Proposed work

    The patient has been discharged back to the practice with a timed request for a review.

    Owner
    Admin team
    Due
    Between 28 Oct and 11 Nov (4–6 weeks)
    Who decides
    Administrative

    Verified when: A blood pressure review recorded in the clinical record between 28 Oct and 11 Nov 2026. A booking alone is not enough. Source: Clinical record, by design; simulated here.

    Limit It shows that the review took place, not what was decided.

    Reedley does not message or book patients. The practice uses its own tools.

    Reedley proposes; a named person decides. Nothing happens until you do.

  5. Item 5 of 5: Result reviewClinician review of the renal function resultAfter the result

    From the document

    Proposed work

    The test is requested so that a clinician looks at renal function after the dose change. Reedley does not interpret the result.

    Owner
    Clinical pharmacist
    Due
    When the result is received
    Who decides
    Prescriber review required
    After
    Item 2: Renal function 1–2 weeks after any dose change

    Verified when: A review of the U&E result recorded by a named clinician, with the date. Source: Clinical record, by design; simulated here.

    Limit It shows that a review was recorded, not what it concluded. Reedley does not interpret results.

    Reedley does not say what the result means or what to do. A clinician decides.

    Reedley proposes; a named person decides. Nothing happens until you do.

For information · no action proposed

What the record shows (synthetic)

Current medicines

  • Ramipril 5 mg capsules One daily Repeat
  • Amlodipine 10 mg tablets One daily Repeat

Problems

Essential hypertension

Latest

#5 · 4 Oct 10:05 · Reedley Routed to a clinician (GP) · Clinician decision on the conditional amlodipine advice

Synthetic data · Illustrative concept · Not clinical rules · Not a live system · Source checks are simulated

 

What the demonstration does not show

Real accuracy. These outputs were written in advance. They do not show how often the product extracts information correctly from real documents; that has not yet been measured.

Real integration. There is no connection to EMIS Web, SystmOne or any laboratory, and nothing is written to any record. “Source checks” are simulated to show how verification is meant to work once approved access exists.

Clinical rules. Intervals, routing rules and wording are illustrative. In the product, clinical rules are designed to be owned by named clinicians and versioned; today they are unsigned drafts with no named owner.

Next steps

See it on your own workflows.

In a pilot, your team would test Reedley on synthetic patients built around your real workflows before anything else happens.

  1. See it work

    A scripted walkthrough of a synthetic clinic letter, from receipt to evidence. Pause or step through it at any point.

    Take the 90-second tour
  2. Share it

    Ten short sections for partners, PCN leads and digital staff, written to be forwarded without a conversation first.

    Read the evaluation pack
  3. Talk to us

    Registering interest takes about a minute. A conversation is with Salim Miah, founder (MPharm, independent prescriber).

Questions buyers ask

What will it cost?

Pricing has not been set. Pilot participation would be agreed individually; we will not ask a practice to pay for something that is not ready.

Who is building Reedley?

Reedley is at an early stage and is currently founder-led. Its founder, Salim Miah MPharm, is a UK-qualified pharmacist and independent prescriber who has worked across community pharmacy, hospital and general practice.

As Reedley grows, clinical safety, engineering and information governance roles will be filled by suitably qualified people, and we will name them here.

How much of our team’s time does a pilot take?

Stage 1 is about an hour; registering interest takes about a minute and applying about five minutes.

Stages 2–4 are agreed with you in the conversation; we will not guess.

Does it work with EMIS Web or SystmOne?

Not today. Reedley is designed around EMIS Web workflows, but no integration exists, none is claimed, and no supplier has approved or partnered with Reedley.

We intend to pursue the published integration routes, such as IM1 pairing, and will report each step on the integration page.

The same applies as for EMIS Web: designed for SystmOne workflows, with no integration existing or claimed.

All questions and answers